Literature DB >> 11697848

Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma.

M J Edwards1, R Walker, S Vinnicombe, C Barlow, P MacCallum, J M Foran.   

Abstract

A 63-year-old female with stage IE diffuse large B-cell lymphoma developed reversible posterior leukoencephalopathy syndrome (RPLS) following CHOP chemotherapy, with typical clinical and radiological findings. RPLS is a rare neurological syndrome characterised by visual disturbances, seizures, headaches and altered conscious level which has been associated with malignant hypertension, pre-eclampsia and some drugs, including ciclosporin. It has not been previously reported following CHOP chemotherapy. Alternative treatment should be considered for patients who develop this rare complication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11697848     DOI: 10.1023/a:1012248800195

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  14 in total

1.  Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors:  Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal:  J Med Toxicol       Date:  2010-06

2.  Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen.

Authors:  Franck Bürki; Kattalin Badie; Philippe Bartoli; Pascale Bernard; Jean Louis Montastruc; Haleh Bagheri
Journal:  Br J Clin Pharmacol       Date:  2008-02-15       Impact factor: 4.335

3.  Cyclophosphamide-induced reversible posterior leukoencephalopathy syndrome.

Authors:  Maria Jose Abenza-Abildua; Blanca Fuentes; Domingo Diaz; Aranzazu Royo; Teresa Olea; Maria Jose Aguilar-Amat; Exuperio Diez-Tejedor
Journal:  BMJ Case Rep       Date:  2009-05-25

4.  Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: A case report and literature review.

Authors:  Changqing Xie; Vovanti T Jones
Journal:  Oncol Lett       Date:  2015-12-24       Impact factor: 2.967

5.  [Postoperative occurrence of reversible posterior encephalopathy in a patient with Crohn's disease].

Authors:  S G Zipper; M Tischendorf; K Westphal
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

6.  Posterior reversible leukoencephalopathy syndrome secondary to hepatic transarterial chemoembolization with doxorubicin drug eluting beads.

Authors:  C Andrew Kistler; Joseph Caleb McCall; Saad Sultan Ghumman; Ijlal Akbar Ali; Ali A Siddiqui
Journal:  J Gastrointest Oncol       Date:  2014-04

7.  The role of tumor lysis in reversible posterior leukoencephalopathy syndrome.

Authors:  Emiko Kaito; Satoshi Terae; Ryoji Kobayashi; Kohsuke Kudo; Khin Khin Tha; Kazuo Miyasaka
Journal:  Pediatr Radiol       Date:  2005-03-09

8.  Reversible Posterior Leukoencephalopathy Syndrome Due to Carboplatin and Paclitaxel Therapy.

Authors:  Melek Kandemir; Belgin Küçükkaya; Muzaffer Savaş Tepe; Zehra Betül Yalçıner; Nedret Taflan Salepçi
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

9.  Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis.

Authors:  Toshiyuki Ohta; Takashi Sakano; Mami Shiotsu; Takeki Furue; Hideyuki Ohtani; Yoshihisa Kinoshita; Tatsuya Mizoue; Katsuzo Kiya; Issei Tanaka
Journal:  Pediatr Nephrol       Date:  2003-12-16       Impact factor: 3.714

10.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.